Publication | Open Access

Effects of avitriptan, a new 5-HT1B/1D receptor agonist, in experimental models predictive of antimigraine activity and coronary side-effect potential

Antimigraine ActivityCardiovascular DiseaseFunctional SelectivityMedicineExperimental ModelsExperimental PharmacologyPharmacotherapyCoronary Side-effect PotentialPharmacologyDrug Discovery